Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nicotinamide Riboside Impact on Extracellular Nicotinamide Adenine Dinucleotide (NAD+)
Sponsor: Charite University, Berlin, Germany
Summary
The investigation is a clinical study in which the impact of taking the dietary supplement nicotinamide riboside (NR) on the concentration of extracellular nicotinamide adenine dinucleotide (eNAD+) in human plasma over time will be determined. The study will be conducted in a randomized, double-blinded, and placebo-controlled manner.
Official title: Validation of an Enzymatic Assay for Quantification of Nicotinamide Adenine Dinucleotide in Blood Plasma After Ingestion of the Vitamin B3 Variant Nicotinamide Riboside: a Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
54
Start Date
2023-11-01
Completion Date
2024-12-31
Last Updated
2024-06-13
Healthy Volunteers
Yes
Conditions
Interventions
Niagen
Nicotinamide-Riboside-Chloride Preparation 1000mg/day
Placebo
Placebo Preperation
Locations (1)
Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte, Charité - Universitätsmedizin Berlin
Berlin, Germany